Researchers at the University of Oxford in the U.K. have concluded that hydroxychloroquine does nothing to prevent COVID-19-related deaths.
The research is a continuation of a major clinical trial that found that the drug — which has previously been touted by President Donald Trump and White House trade adviser Peter Navarro — had no clinical benefit.
The study, published in the New England Journal of Medicine, examined the outcomes of 1,561 patients hospitalized with COVID-19 who received hydroxychloroquine and compared them to 3,155 patients who served as a control group.
Within a month, about a quarter of the patients in each group had died.
There was also a slightly higher number of heart-related deaths in the hydroxychloroquine group; however, that finding was not robust enough to be statistically significant — meaning it could have been due to chance.
“The scientific evidence is clear,” said Dr. Caleb Alexander, a professor of